Latest
The impact of an expanded TRIPS waiver on existing and future biopharmaceutical innovation
Data shows that intellectual property rights have been vital to developing the most important innovative Covid medicines.
Localisation barriers to trade in the biopharmaceutical industry
Forcing biopharmaceutical companies to locate operations within countries as a condition of market access could undermine both investment and access to medicines.
Featured
Trade secrecy and Covid-19
This policy brief documents how trade secrets have played a key role in enabling the innovation, investment and collaboration that has delivered Covid-19 vaccines in record time.
Five reasons the TRIPS waiver should not be expanded to covid therapeutics
An expanded waiver would derail current successful efforts to expand access to Covid treatments and destroy innovation incentives
Innovation principles for the treaty on pandemic preparedness
IP rights are crucial for pandemic preparedness, says think tank coalition.
Why patents matter to Indonesia
With careful reform of its patent law etc, Indonesia can accelerate its transition to a knowledge-based, wealthy economy
Localisation barriers to trade in the biopharmaceutical industry
Forcing biopharmaceutical companies to locate operations within countries as a condition of market access could undermine both investment and access to medicines.
Criação de um sistema de patentes previsível e estável no Brazil
Nossa agenda de reformas para atualizar o sistema brasileiro de exame de patentes para padrões internacionais.
